deferoxamine has been researched along with Deafness in 4 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehne, N | 1 |
| Lautermann, J | 1 |
| Petrat, F | 1 |
| Rauen, U | 1 |
| de Groot, H | 1 |
| Guerin, A | 1 |
| London, G | 1 |
| Marchais, S | 1 |
| Metivier, F | 1 |
| Pelisse, JM | 1 |
| Cases, A | 1 |
| Campistol, JM | 1 |
| Sabater, M | 1 |
| López-Pedret, J | 1 |
| Revert, L | 1 |
| Marumo, F | 1 |
| Umetani, N | 1 |
| Sato, N | 1 |
| Takahashi, Y | 1 |
4 other studies available for deferoxamine and Deafness
| Article | Year |
|---|---|
Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
Topics: 2,2'-Dipyridyl; Aminoquinolines; Animals; Antineoplastic Agents; Calcium; Cell Death; Chelating Agen | 2001 |
Acute deafness and desferrioxamine.
Topics: Acute Disease; Adult; Deafness; Deferoxamine; Female; Humans | 1985 |
Desferrioxamine-induced acute neurosensorial deafness.
Topics: Acute Disease; Adult; Deafness; Deferoxamine; Female; Humans; Kidney Failure, Chronic | 1988 |
Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Calcitriol; Calcium; Deafness; Deferoxamine; Eye; Humans; R | 1987 |